431 filings
Page 18 of 22
8-K
c0phnd
8 Dec 15
Other Events
12:00am
8-K
4s36xu1dv wja0
4 Dec 15
Other Events
12:00am
424B3
m986kscdqzprci4akl17
4 Dec 15
Prospectus supplement
12:00am
424B3
j4s606c7 4m01qhxxi
12 Nov 15
Prospectus supplement
12:00am
8-K
iq8zxalenn3pwh0jy9t2
12 Nov 15
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Third Quarter 2015 Financial Results
12:00am
8-K
0olu6c cz3
5 Nov 15
Onconova Announces Data Presentation from Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at the 2015 ASH Annual Meeting
12:00am
EFFECT
5wxxfrjck4svquv03qdn
3 Nov 15
Notice of effectiveness
12:00am
424B3
01l90e u510yb
3 Nov 15
Prospectus supplement
12:00am
CORRESP
ktsg9mtt nwp
2 Nov 15
Correspondence with SEC
12:00am
UPLOAD
9jemv02vl3rc1mzx
2 Nov 15
Letter from SEC
12:00am
D
cvgfehmnd1ggeflj7kzi
23 Oct 15
$16.5M in equity, sold $1.5M, 1 investor
12:00am
8-K
x1t deie9
8 Oct 15
Onconova Therapeutics Announces $16.5M Share Purchase Agreement with Lincoln Park Capital Fund
12:00am
8-K
70fh7lld
5 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
r3kvxf8abzsfln
13 Aug 15
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2015 Financial Results
12:00am
8-K
2n8el1
8 Jul 15
Results of Operations and Financial Condition
12:00am
8-K
he2r7dyl
17 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am